Home › Asset managers › Compare 2024-2025 › ProShares vs Brighthouse
Note on Brighthouse: its funds did not all vote the same way on 14.6% of the 98,076 ballot items it voted. Those items are not in the percentage above; the ones it shares with this pair are listed under “Split votes”.
ProShares 2024-2025 · Brighthouse 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 25,149 | 13,786 | 100 | 11,263 | 99.3% | 85.9% |
| Board proposals | 23,318 | 12,718 | 94 | 10,506 | 99.3% | 86.2% |
| E&S shareholder proposals | 256 | 1 | 3 | 252 | 25.0% | 43.9% |
| Other items | 1,575 | 1,067 | 3 | 505 | 99.7% | 88.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
11,363 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | ProShares | Brighthouse |
|---|---|---|---|---|---|---|
| LYFT INC. | June 5, 2025 | Stockholder proposal regarding an assessment of Lyft's use of artificial intelligence, if properly presented at the meeting. Human Rights or Human Capital/workforce |
Shareholder (E&S) | Contested | AGAINST 1 fund |
ABSTAIN 5 funds |
| PENN ENTERTAINMENT INC. | June 17, 2025 | The Company's proposal to approve, on an advisory basis, the commissioning of a report on the effects of a company-wide non-smoking policy. Other Social Issues |
Shareholder (E&S) | Contested | AGAINST 3 funds |
ABSTAIN 3 funds |
| SPIRIT AEROSYSTEMS HOLDINGS INC. | May 23, 2025 | The Stockholder Proposal titled "Transparency in Political Spending" Other Social Issues |
Shareholder (E&S) | Against | FOR 1 fund |
ABSTAIN 2 funds |
| CHEWY | July 11, 2024 | To approve an amendment to the Amended and Restated Certificate of Incorporation to provide for the exculpation of certain officers as permitted by recent amendments to Delaware law. Corporate Governance |
Other | For | AGAINST 3 funds |
ABSTAIN 1 fund |
| COCA-COLA FEMSA SAB DE CV | April 8, 2025 | APPROVE FINANCIAL STATEMENTS AND STATUTORY REPORTS Corporate Governance |
Other | For | FOR 1 fund |
AGAINST 2 funds |
| PENNON GROUP PLC | July 24, 2024 | Approve Climate-Related Financial Disclosures Environment or Climate |
Other | For | FOR 1 fund |
AGAINST 1 fund |
| ALECTOR INC. | June 11, 2025 | Advisory vote on executive compensation. Say-on-Pay |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| ALECTOR INC. | June 11, 2025 | Ratification of the appointment of Ernst & Young, LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| ALX ONCOLOGY HOLDINGS INC | June 11, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
ABSTAIN 1 fund |
| ALX ONCOLOGY HOLDINGS INC | June 11, 2025 | Ratification of the appointment of KPMG LLP as the independent registered public accounting firm for our fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to appoint Ernst & Young LLP as auditors of the Company to hold office until the conclusion of the next general meeting at which annual accounts are laid before the Company and to authorize the Audit Committee of the Board of Directors of the Company to agree the auditors' remuneration as described in full on pages 11 to 12 of the accompanying Proxy Statement. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to generally and unconditionally authorize the Board of Directors of the Company (the "Board") to allot shares in the Company or grant rights to subscribe for or to convert any security into shares of the Company up to an aggregate nominal amount of pounds38,400,000 (which is equal to approximately 18% of the existing issued share capital) as described in full on pages 13 to 14 of the accompanying Proxy Statement; and Capital Structure |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to hold an advisory (non-binding) vote to approve the compensation of the Company's "named executive officers" as described in full in the "Executive Compensation Discussion and Analysis" section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure on pages 26 to 58 of the accompanying Proxy Statement. Say-on-Pay |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to re-elect Mr. Aaron Berg as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to re-elect Mr. Keith L. Horn as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to re-elect Mr. Louis Sterling III as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to re-elect Mr. Michael Torok as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to re-elect Mr. Odysseas Kostas, M.D. as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to re-elect Mr. Paul Cohen, M.D. as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to re-elect Ms. Diane E. Sullivan as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AMARIN CORPORATION PLC | May 13, 2025 | Ordinary resolution to re-elect Ms. Patrice Bonfiglio as a director. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| AUTOLIV INC. | May 8, 2025 | Election of Directors: Franz-Josef Kortum Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| AUTOLIV INC. | May 8, 2025 | Election of Directors: Frederic Lissalde Director Elections |
Board | For | FOR 7 funds |
WITHHOLD 1 fund |
| CENTESSA PHARMACEUTICALS PLC | June 20, 2025 | To generally and unconditionally authorise the directors of the Company or any duly authorised committee of the directors, in accordance with section 551 of the UK Companies Act 2006 (the "Companies Act"), to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of pounds133,184. Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CENTESSA PHARMACEUTICALS PLC | June 20, 2025 | To re-appoint as a director Samarth Kulkarni, Ph.D., who retires by rotation in accordance with the Company's articles of association. Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| CHEWY INC. | July 11, 2024 | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | AGAINST 3 funds |
ABSTAIN 1 fund |
| CHEWY INC. | July 11, 2024 | To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending February 2, 2025. Audit-related |
Board | For | FOR 3 funds |
ABSTAIN 1 fund |
| CHINA CONSTRUCTION BANK CORP. | April 22, 2025 | Approve Annual Issuance Plan for the Group's Financial Bonds Capital Structure |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| COHERUS BIOSCIENCES INC. | June 11, 2025 | To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
| COHERUS BIOSCIENCES INC. | June 11, 2025 | To vote on a non-binding, advisory basis to approve the compensation of the Company's named executive officers (a "Say-on-Pay" vote). Say-on-Pay |
Board | For | AGAINST 8 funds |
ABSTAIN 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 6.b Binding vote on maximum equity for members of the Board of Directors from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 6.c Binding vote on maximum non-performance-related compensation for members of the Executive Committee from July 1, 2025 to June 30, 2026. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 6.d Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2025. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CRISPR THERAPEUTICS AG | June 5, 2025 | 6.e Binding vote on maximum equity for members of the Executive Committee from the 2025 Annual General Meeting to the 2026 annual general meeting of shareholders. Compensation |
Board | For | AGAINST 4 funds |
FOR 1 fund |
| CVS GROUP PLC | November 20, 2024 | Approve Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| E.W. SCRIPPS CO. | May 5, 2025 | Election of Directors: Burton F. Jablin Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 1 fund |
| E.W. SCRIPPS CO. | May 5, 2025 | Election of Directors: Nishat A. Mehta Director Elections |
Board | For | FOR 8 funds |
WITHHOLD 1 fund |
| ENGHOUSE SYSTEMS LTD | March 10, 2025 | ELECTION OF DIRECTOR: MELISSA SONBERG Director Elections |
Board | Not determined | FOR 1 fund |
WITHHOLD 1 fund |
| ENGHOUSE SYSTEMS LTD | March 10, 2025 | ELECTION OF DIRECTOR: PAUL STOYAN Director Elections |
Board | Not determined | FOR 1 fund |
WITHHOLD 1 fund |
| ENGHOUSE SYSTEMS LTD | March 10, 2025 | ELECTION OF DIRECTOR: PIERRE LASSONDE Director Elections |
Board | Not determined | FOR 1 fund |
WITHHOLD 1 fund |
| ENGHOUSE SYSTEMS LTD. | March 10, 2025 | Advisory Vote on Executive Compensation Approach Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ERAMET SA | May 26, 2025 | Reelect Christel Bories as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ERAMET SA | May 26, 2025 | Reelect Christine Coignard as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| ERAMET SA | May 26, 2025 | Reelect Solenne Lepage as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| EUTELSAT COMMUNICATIONS SA | November 21, 2024 | Approve Compensation of Eva Berneke, CEO Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| EUTELSAT COMMUNICATIONS SA | November 21, 2024 | Reelect Eva Berneke as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FLUGHAFEN ZUERICH AG | April 14, 2025 | Reappoint Claudia Pletscher as Member of the Nomination and Compensation Committee Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FLUGHAFEN ZUERICH AG | April 14, 2025 | Reappoint Guglielmo Brentel as Member of the Nomination and Compensation Committee Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FLUGHAFEN ZUERICH AG | April 14, 2025 | Reappoint Josef Felder as Non-Voting Member of the Nomination and Compensation Committee Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FLUGHAFEN ZUERICH AG | April 14, 2025 | Reelect Claudia Pletscher as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FLUGHAFEN ZUERICH AG | April 14, 2025 | Reelect Guglielmo Brentel as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FLUGHAFEN ZUERICH AG | April 14, 2025 | Reelect Josef Felder as Board Chair Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FLUGHAFEN ZUERICH AG | April 14, 2025 | Reelect Josef Felder as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| FOGHORN THERAPEUTICS INC. | June 17, 2025 | To ratify the selection of Deloitte & Touche LLP as the independent registered public accounting firm for the Company for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 9 funds |
ABSTAIN 1 fund |
| GOLD ROAD RESOURCES LTD. | May 16, 2025 | Elect Denise McComish as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| GOPRO INC. | June 3, 2025 | Approval of the non-binding, advisory resolution on executive compensation. Say-on-Pay |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
| GOPRO INC. | June 3, 2025 | Ratification of the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
| HANKOOK & COMPANY CO. LTD. | March 26, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| HMM CO. LTD. | March 26, 2025 | Elect Choi Won-hyeok as Inside Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| HMM CO. LTD. | March 26, 2025 | Elect Lee Jeong-yeop as Inside Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| HUAIBEI MINING HOLDINGS CO. LTD. | September 26, 2024 | Elect Pei Renyan as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| IMMUNOCORE HOLDINGS PLC | May 15, 2025 | To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the proxy statement, which will take effect immediately after the end of the AGM. Compensation |
Board | For | AGAINST 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 15, 2025 | To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement. Say-on-Pay |
Board | For | AGAINST 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 15, 2025 | To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending December 31, 2025. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 15, 2025 | To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 15, 2025 | To re-appoint as a director Professor Sir Peter Ratcliffe, who retires in accordance with the articles of association. Director Elections |
Board | For | AGAINST 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 15, 2025 | To re-appoint as a director Ranjeev Krishana, who retires in accordance with the articles of association. Director Elections |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| IMMUNOCORE HOLDINGS PLC | May 15, 2025 | To re-appoint as a director Roy S. Herbst, M.D., Ph.D., who retires in accordance with the articles of association. Director Elections |
Board | For | AGAINST 1 fund |
ABSTAIN 1 fund |
| INDIVIOR PLC | May 8, 2025 | Approve Remuneration Policy Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| INDIVIOR PLC | May 8, 2025 | Approve Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| INTERNATIONAL BANCSHARES CORP. | May 19, 2025 | ELECTION OF DIRECTORS: R. R. Resendez Director Elections |
Board | For | FOR 20 funds |
ABSTAIN 1 fund |
| ITC LTD. | April 10, 2025 | Approve Extension of Benefits of the ITC Employee Stock Appreciation Rights Scheme 2025 to such Permanent Employees, including Managing/Wholetime Directors Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| ITC LTD. | April 10, 2025 | Approve Grant and Issuance of Equity Settled Stock Appreciation Rights under ITC Employee Stock Appreciation Rights Scheme 2025 (ITC ESAR Scheme) Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| JAKKS PACIFIC INC. | June 20, 2025 | To conduct an advisory vote on executive compensation. Say-on-Pay |
Board | For | AGAINST 8 funds |
ABSTAIN 1 fund |
| JAKKS PACIFIC INC. | June 20, 2025 | To ratify the selection of the firm of BDO USA as the Company's independent auditors for the current fiscal year. Audit-related |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
| KLAVIYO INC. | June 10, 2025 | To approve, on a non-binding advisory basis, the compensation of Klaviyo's named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
ABSTAIN 2 funds |
| KLAVIYO INC. | June 10, 2025 | To ratify the appointment of Deloitte & Touche LLP as Klaviyo's independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 2 funds |
| KRAFTON INC. | March 26, 2025 | Approve Financial Statements and Allocation of Income Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| NASPERS LTD. | August 22, 2024 | Approve Financial Assistance in Terms of Section 44 of the Companies Act Capital Structure |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| NASPERS LTD. | August 22, 2024 | Re-elect Craig Enenstein as Director Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| NASPERS LTD. | August 22, 2024 | Re-elect Steve Pacak as Chairman of the Audit Committee Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| NETEASE INC. | June 25, 2025 | Elect Joseph Tze Kay Tong as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| NETEASE INC. | June 25, 2025 | Elect Michael Man Kit Leung as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| NEWAMSTERDAM PHARMA COMPANY N.V. | June 4, 2025 | Extension of authorization for the Board of Directors to acquire ordinary shares and depository receipts for ordinary shares in the Company's capital. Capital Structure |
Board | For | AGAINST 1 fund |
FOR 4 funds |
| ONEX CORP. | May 8, 2025 | Advisory Vote on Executive Compensation Approach Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| PACIFIC METALS CO. LTD. | June 25, 2025 | Elect Director Iwadate, Kazuo Director Elections |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| PLDT INC. | June 10, 2025 | Elect Artemio V. Panganiban as Director Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 2 funds |
| PLDT INC. | June 10, 2025 | Elect Bernadine T. Siy as Director Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 2 funds |
| PLDT INC. | June 10, 2025 | Elect Bernido H. Liu as Director Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 2 funds |
| RAI WAY SPA | April 30, 2025 | Approve Second Section of the Remuneration Report Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| SHENZHEN EXPRESSWAY CORPORATION LTD. | September 20, 2024 | Approve Extension of the Validity Period of the Resolutions and Mandate in Relation to the Issuance of A Shares to Specific Target Capital Structure |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| TEMPUS AI INC. | May 20, 2025 | To approve the reincorporation of the Company from the State of Delaware to the State of Nevada by conversion. Extraordinary Transactions |
Board | For | AGAINST 1 fund |
ABSTAIN 1 fund |
| TEMPUS AI INC. | May 20, 2025 | To ratify the appointment by the Audit Committee of the Board of Directors of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 1 fund |
ABSTAIN 1 fund |
| VALE SA | April 30, 2025 | Elect Daniel Andre Stieler as Board Chair Corporate Governance |
Board | For | FOR 4 funds |
ABSTAIN 1 fund |
| VERONA PHARMA PLC | April 24, 2025 | To re-elect Kenneth Cunningham, M.D. as a director of the Company. Director Elections |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| VIRBAC SA | June 19, 2025 | Reelect Cyrille Petit Conseil as Director Director Elections |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| YEALINK NETWORK TECHNOLOGY CO. LTD. | June 17, 2025 | Approve Authorization of the Board to Handle All Matters Related to Partner Share Purchase Plan Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| YEALINK NETWORK TECHNOLOGY CO. LTD. | June 17, 2025 | Approve Draft and Summary of Partner Share Purchase Plan Compensation |
Board | For | AGAINST 1 fund |
FOR 1 fund |
| ZENTALIS PHARMACEUTICALS INC. | June 17, 2025 | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers. Say-on-Pay |
Board | For | AGAINST 8 funds |
ABSTAIN 1 fund |
| ZENTALIS PHARMACEUTICALS INC. | June 17, 2025 | To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Audit-related |
Board | For | FOR 8 funds |
ABSTAIN 1 fund |
Page 1 of 114 Next →
How items are matched and positions counted: see the comparison table and the methodology. Built October 13, 2026 from SEC Form N-PX filings.